Skip to main content
Robert Ratner, MD, Endocrinology, Washington, DC, MedStar Washington Hospital Center

RobertEdwardRatnerMD

Endocrinology Washington, DC

Diabetes, Lipid Metabolism

Professor, Medicine, Georgetown University School of Medicine

Dr. Ratner is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Ratner's full profile

Already have an account?

Summary

  • Dr. Robert Ratner is an endocrinologist in Washington, DC on faculty in the Division of endocrinology and metabolism at Georgetown University. He is chief medical officer at Virta Health. He received his medical degree from Baylor College of Medicine and has been in practice 40 years. He Served as chief scientific and medical officer for the American Diabetes Association from 2012-2016.

Education & Training

  • Beth Israel Deaconess Medical Center
    Beth Israel Deaconess Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 1980 - 1982
  • Baylor College of Medicine
    Baylor College of MedicineResidency, Internal Medicine, 1977 - 1980
  • Baylor College of Medicine
    Baylor College of MedicineClass of 1977

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 1993 - 2017
  • DC State Medical License
    DC State Medical License 1982 - 2013

Awards, Honors, & Recognition

  • Super Doctor SuperDoctors.com
  • Fellow (FACE) American Association of Clinical Endocrinology

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • Clinical Diabetes and Endocrinology in 2013 
    National Jewish Health, Snowmass, Colorado - 1/19/2013
  • Practical Ways to Achieve Targets in Diabetes Care 
    University of Colorado Denver, Keystone, Colorado - 7/12/2012

Press Mentions

  • Meet the New Chief Science Guy at the American Diabetes Association
    Meet the New Chief Science Guy at the American Diabetes AssociationMarch 7th, 2017
  • The Cost-Effectiveness of Lifestyle Modification or Metformin in Preventing Type 2 Diabetes in Adults with Impaired Glucose Tolerance
    The Cost-Effectiveness of Lifestyle Modification or Metformin in Preventing Type 2 Diabetes in Adults with Impaired Glucose ToleranceMarch 1st, 2005
  • Human Gut Microbiome May Help Identify New Ways of Preventing and Treating Diabetes
    Human Gut Microbiome May Help Identify New Ways of Preventing and Treating DiabetesMay 31st, 2016
  • Join now to see all

Grant Support

  • Diabetes Prevention Program Outcomes Study - Phase 2National Institute Of Diabetes And Digestive And Kidney Diseases2009–2012
  • The Metformin-Exenatide-Insulin (MEXELIN) TrialNational Center For Research Resources2008–2009
  • Long Term DPP Follow-Up StudyNational Institute Of Diabetes And Digestive And Kidney Diseases2003–2008
  • Stop Atherosclerosis In Native Diabetics Study (SANDS)National Heart, Lung, And Blood Institute2006–2007
  • Inhaled Insulin Using The Aerx IDMS VS SC Insulin VIA SyNational Center For Research Resources2005
  • Diabetes Prevention ProgramNational Institute Of Diabetes And Digestive And Kidney Diseases1996–2002
  • Diabetes Prevention Program (Ddd-2)National Institute Of Diabetes And Digestive And Kidney Diseases1998
  • Primary Prevention TrialNational Institute Of Diabetes And Digestive And Kidney Diseases1994–1995

Hospital Affiliations